This project aims to deploy a mHealth assessment system in a national sample of individuals who experience persecutory ideation (PI). Specifically, we will (1) evaluate whether PI with need for clinical care is associated with differential phenomenology of PI – frequency, valence, conviction, appraisals, and behavioral responses, (2) examine relationships between baseline clinical, functional and demographic factors, time-varying contextual factors, and PI, and (3) test relationships posited in the cognitive model of PI.
Patient Population: Adults
Collaborating to Heal Addiction and Mental Health in Primary Care (CHAMP)
The gold-standard intervention for Opioid Use Disorder (OUD) is Medication for Opioid Use Disorder (MOUD). Because more patients with OUD need access to MOUD in primary care, the AIMS Center at the University of Washington is testing a Collaborative Care model to treat mental health disorders and OUD concurrently in primary care settings. The CHAMP study addresses three important objectives including: 1) Can OUD screening be effectively incorporated into primary care mental health screening protocols?; 2) Does implementing Collaborative Care for OUD and mental health disorders improve outcomes?; 3) What implementation strategies are effective at sustaining Collaborative Care programs that concurrently manage mental health disorders and OUD? In this pragmatic trial, 24 primary care clinics will be randomized to either adding OUD to their Collaborative Care program or maintaining Collaborative Care for mental health disorders only.
Study to Promote Innovation in Rural Integrated Telepsychiatry (SPIRIT)
The primary goal of this project is to quantitatively compare the treatment experience, engagement, self-reported clinical outcomes, and recovery-oriented outcomes of patients initially randomized to telepsychiatry collaborative care and telepsychiatry enhanced referral. In addition, for the subset of patients randomized to telepsychiatry enhanced referral who do not engage in treatment and are still symptomatic at 6 months, an additional goal is to quantitatively compare the treatment experience, treatment engagement, self-reported clinical outcomes and recovery-oriented outcomes of patients randomized to continued- telepsychiatry enhanced referral or phone enhanced referral. Additional goals are to gain an in-depth understanding of patients’ and providers’ treatment experiences and to examine treatment heterogeneity among subgroups of patients based on race/ethnicity, age and clinical severity.
Premera rural mental health initiative
The AIMS Center is partnering with Premera to support up to 30 clinics in rural Washington and Alaska to expand access to evidence-based mental health treatment. Selected clinics will receive up to $245,000 over 15 months to defray participation costs.
